Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Cholangiocarcinoma
Description
A malignant tumor arising from the epithelium of the BILE DUCTS. MeSH
Hierarchy View
Subtype Terms (1)
Klatskin Tumor
19 drugs (14 approved, 5 experimental)
Approved Indicated Drugs (3)
Phase 3 Indicated Drugs (21)
Phase 1 Indicated Drugs (53)
Other Experimental Indicated Drugs (7)
Organization Involved with Phase 4 Indications (18)
Autonomous University of Madrid
Fundación para la Investigación Biomédica del Hospital 12 de Octubre
HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA, SANTANDER
Hospital Universitario Ntra. Sra. de La Candelaria
Organization Involved with Phase 3 Indications (54)
Australasian Gastro-Intestinal Trials Group
Centre Georges Francois Leclerc
Federation Francophone de Cancerologie Digestive
KWF Kanker Bestrijding The Netherlands
Organization Involved with Phase 2 Indications (153)
Beijing InnoCare Pharma Tech Co., Ltd.
Cantonal Hospital of St. Gallen
Case Western Reserve University
Chinese University of Hong Kong
ECOG-ACRIN Cancer Research Group
Gottfried Wilhelm Leibniz Universität Hannover
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Hannover Clinical Trial Center GmbH
Hellenic Cooperative Oncology Group
Hoosier Cancer Research Network
IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest
Innovent Biologics (Suzhou) Co. Ltd.
Istituto Clinico Humanitas - Rozzano (MI), Italy
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Memorial Sloan-Kettering Cancer Center
National Cheng Kung University
National Institutes of Health (NIH)
National Science and Technology Development Agency, Thailand
New Mexico Cancer Care Alliance
Northern Institute for Cancer Research Newcastle
Oregon Health and Science University
People's Liberation Army of China
Shanghai Junshi Bioscience Co.,Ltd.
Shanghai Xuhui District Central Hospital
Simcere Pharmaceutical Co., Ltd
State University of New York, Buffalo
Swiss Group for Clinical Cancer Research
Taichung Veterans General Hospital
Technical University of Dresden
Technical University of Munich
The University of Texas, Dallas
University of California, Davis
University of California, San Francisco
University of Colorado, Denver
University of Southern California
University of Southern Denmark
University of Texas at Houston
University of Texas, Galveston
Organization Involved with Phase 1 Indications (35)
Organization Involved with Other Experimental Indications (9)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.